1 APPENDIX 4E PRELIMINARY FINAL REPORT TO 30 JUNE 2026 KEY POINTS: • Key results (unaudited) as follows: • FY26 Revenue $8.5m (Receipts $5.2m) down 56% from FY25 • FY26 Other Income $5.4m up 929% from FY25 • FY26 positive EBITDA...
Preliminary Final Report
Filed with ASX · · 25 pages · English
Summary by 6ix AI
The report highlights a significant decline in revenue compared to the previous year, alongside a notable increase in other income and a positive EBITDA. Delorean's flagship bioenergy facility is nearing completion, with expectations for operational revenue to begin in the upcoming financial year. The company is actively pursuing additional funding for its projects and has strengthened its position in the renewable gas market through strategic partnerships.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Delorean Corporation Ltd on 6ix
Earlier from Delorean
- Quarterly Activities/Appendix 4C Cash Flow Report
- $1.66 Million Grant cash payment received
- Additional $1.66 Million ARENA Grant For SA1
- SA1 Accredited for GreenPower Renewable Gas Certification
- Completion of Share Purchase Plan
Later from Delorean
- Results Presentation
- Opal / Delorean Concept Stage Completion
- Appendix 4E Variance Report
- FY26 Annual Report
- FY26 Corporate Governance Statement
Follow Delorean into a list and get an email when it puts out news.
Follow Delorean